PatientsVille.com Logo

PULMONARY EMBOLISM and ACIPHEX

PatientsVille

PULMONARY EMBOLISM Symptoms and Causes

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung. Pulmonary embolism is a serious condition that can cause

  • Permanent damage to the affected lung
  • Low oxygen levels in your blood
  • Damage to other organs in your body from not getting enough oxygen

If a clot is large, or if there are many clots, pulmonary embolism can cause death.

Half the people who have pulmonary embolism have no symptoms. If you do have symptoms, they can include shortness of breath, chest pain or coughing up blood. Symptoms of a blood clot include warmth, swelling, pain, tenderness and redness of the leg. The goal of treatment is to break up clots and help keep other clots from forming.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for PULMONARY EMBOLISM

PULMONARY EMBOLISM treatment research studies

ACIPHEX clinical trials, surveys and public health registries


Find Drug Side Effect reports



ACIPHEX Side Effects

Pain (30)
Headache (27)
Fatigue (24)
Nausea (24)
Dizziness (23)
Dyspnoea (22)
Chest Pain (22)
Diarrhoea (21)
Abdominal Pain Upper (19)
Pneumonia (18)
Cholecystitis Chronic (18)
Hypertension (17)
Oedema Peripheral (16)
Anxiety (16)
Cholelithiasis (16)
Myocardial Infarction (16)
Pruritus (15)
Pain In Extremity (14)
Depression (14)
Fall (13)
Loss Of Consciousness (13)
Dyspepsia (13)
Death (13)
Gallbladder Disorder (12)
Abdominal Pain (12)
Weight Decreased (12)
Asthenia (11)
Cerebrovascular Accident (11)
Feeling Abnormal (10)
Chronic Obstructive Pulmonary Disease (10)
Hypoaesthesia (10)
Rash (10)
Insomnia (10)
Pulmonary Embolism (10)
Paraesthesia (10)
Palpitations (10)
Injury (10)
Burning Sensation (9)
Muscle Spasms (9)
Chest Discomfort (9)
Arthralgia (9)
Deep Vein Thrombosis (8)
Emotional Distress (8)
Nephritis Interstitial (8)
Vomiting (8)
Cough (8)
Back Pain (8)
Cardiac Failure Congestive (8)
Condition Aggravated (8)
Coronary Artery Disease (8)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I was having frequent leg cramps. They worked their way from my foot up to my thigh. I just thought it was from stopping the use of muscle relaxers ( for a serious back and neck problem). I had forgotten about them and never mentioned it to either

Have experienced polyneuropathy after taking aciphex this past year

I am a 28 year old female who was diagnosed 3 years ago with a hiatal hernia, 9 stomach ulcers and constant gastritis. They put me on aciphex. I have been on it ever since as it is the only thing that stops the pain. Just recently (within the

I have been taking aciphex for 7 days dont seem to be any different wonder if it takes a bit for it to work anyone else have this problem.

In Oct. 2009 I went to the Emergency Room of my local hospital for a shortness of breath as I was struggling to catch my breath. I was asked if I had chest pain and responded no, just difficulty breathing. I was given morphine, pr

My father died suddenly of a pulmonary Embolism with no signs or symtoms. We are devasted.....but the one thing that keeps pulling on my heart strings is he was already on blood thinners for years after his quadrapal by pass 13 years ago. He has been

On the 12th dec2011 i nearly died from a p. e. that had been going on for some time.I had a saddle on my lungs.I was 10 days in hospital & was treated with continued oxygen,clexane injections,warfaring pills,paracetamol pills,antibiotics in

What's on your mind...I am two months post PE after a total knee revision. Then three bleeds into the knee (big hematoma). Week later bleed and fluid into an already bad right shoulder requiring hospitalization. I am improving, however sleep an ext

My father is suffrering from idiotypic Pulmonary Fibrosis. In medication he is taking Prednisone,Perfenodone and azathropine. he is now geeting bleeding from his nose.Can anybody inform me that this is just a side effect of any d

After a pulmunary embolism diagnosis in April 2010, I was put on Warfarin for 11 months ... I was taken off it 1 week ago... While on it I experienced extreme lethargy , difficulty concentrating, memory loss, dizziness, ongoing ch

After being discharged from eER I saw in my file that the doppler impression shows mild tricuspid regurgitation and mild pulmonary hypertension =-O scared should I be worried

Completed course of interferon and ribavirn for Hepititis C. Fell pregnant 5 months after completion of treatment and gave birth to a baby boy weighing 7.6 lbs. He has Trisomy 21. He was born with Persisitant Pulmonary hypertension and a VSD. I do no

Female 39 years old from Denmark. Was treated with Octostim as a test. After drug was administred i experience this: <span style='font-weight: bold;'><a href='http://sideeffects101.com/drug-side-effects/o/octostim-pulmonary-oedema.htm' rel='

Has any one found legal representation willing to pursue pulmonary embolis caused by avandia

Having suffered 3 dvt's, 1 pulmonary embolism, 1 stroke and 2 tis's, I was given Fragmin. I previously had been taking warfarin for about 20 yrs, this ceased to work. I am now told that I have Osteoporosis... I seem to remember along the way that

Hello, im using trabectedin in a few weeks, after using ifoosfamide+doxorrubicin to treat pulmonary methastasis or a synovial sarcoma i am concened about loosin my hair again because it means too much for a woman and is not easy to use a wig in summ

How long can one live with the diagnosis of pulmonary hypertension? I have seen 3 to 5 years but I have had it for well over 10.

Husband has been taking avodart for 3 years. Developed a tightness in lungs, dry, non-productive cough, lungs feel a burning sensation. Thorough heart echo tests done, stress test. chest x-ray, mri, blood work, pulmonary function tests all passed.

PULMONARY EMBOLISM Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding
Condition: Nonvariceal Upper Gastrointestinal Bleeding
Interventions: Drug: Intravenous Omeprazole;   Drug: Oral Rabeprazole
Outcome Measure: This study aims to compare the effect of three-day oral rabeprazole and iv omeprazole on bleeding control in patients with mild to moderate non-variceal UGIB.
2 Unknown  Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole plus aspirin versus rabeprazole plus clopidogrel
Outcome Measures: The primary end point is treatment success (ulcer healing rate).;   The secondary end point is incidence of ulcer bleeding within 12 weeks.
3 Recruiting A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors
Condition: Cancer
Interventions: Drug: Dabrafenib 150 mg twice a day (BID);   Drug: Rabeprazole 40 mg once daily (OD);   Drug: Rifampin 600 mg OD
Outcome Measures: PK assessment (Cmax) of Dabrafenib with and without Rabeprazole or Rifampin;   PK assessment (tmax) of Dabrafenib with and without Rabeprazole or Rifampin;   PK assessment (AUC[0-tau]) of Dabrafenib with and without Rabeprazole or Rifampin;   PK assessment of Dabrafenib co administered with rabeprazole or rifampin;   PK assessment (AUC[0-tau]) of hydroxy-dabrafenib, carboxy-dabrafenib, and desmethyl-dabrafenib;   PK assessment (Cmax and Ctau,) of hydroxy-dabrafenib, carboxy-dabrafenib, and desmethyl-dabrafenib;   PK assessment (tmax) of hydroxy-dabrafenib, carboxy-dabrafenib, and desmethyl-dabrafenib;   Ratio of metabolite to Dabrafenib;   Safety and tolerability assessment to measure vital signs;   Safety and tolerability assessment for 12-lead ECG;   Safety and tolerability assessment for laboratory tests;   Safety and tolerability assessment of dabrafenib in combination with rabeprazole or rifampin;   Concentrations of Rabeprazole in the presence of Dabrafenib;   Concentrations of Rifampin in the presence of Dabrafenib
4 Unknown  Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Condition: Helicobacter Pylori Infection
Interventions: Drug: RA5-RACM7;   Drug: RA3-RACM7;   Drug: RA7-RACM7
Outcome Measure: Eradication rate
5 Recruiting Concomitant Therapy of H. Pylori
Condition: Gastritis, Gastric Ulcer, and Duodenal Ulcer
Intervention: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole
Outcome Measure: Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori
6 Recruiting Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
Condition: Healthy
Interventions: Drug: palbociclib commercial free base;   Drug: famotidine;   Drug: rabeprazole;   Drug: antacid
Outcome Measures: Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - 8)];   Maximum Observed Plasma Concentration (Cmax);   Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast);   Apparent Oral Clearance (CL/F);   Time to Reach Maximum Observed Plasma Concentration (Tmax);   Apparent Volume of Distribution (Vz/F);   Plasma Decay Half-Life (t1/2)
7 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine
Outcome Measures: Recurrent ulcer bleeding;   Lower GI bleeding;   serious cardiothrombotic events
8 Recruiting Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Condition: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
Intervention: Drug: Rabeprazole Sodium
Outcome Measures: Response rate of gastric low-grade MALT lymphoma by eradication of Helicobacter pylori;   Transition rate to secondary therapy for eradication of Helicobacter pylori
9 Unknown  Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: 10RAC+acetylcystein;   Drug: 10RAC+metronidazole
Outcome Measures: Re-eradication rate;   Influence of Participant's CYP2C19 genotype on re-eradication rate
10 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
Outcome Measures: Which treatment yields the higher re-eradication rate of H. pylori infection;   Side effects
11 Recruiting The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD
Condition: Reflux Esophagitis
Intervention: Drug: Newrabell® Tablet 10mg
Outcome Measures: Time to onset of first 1Day Heartburn free, Days;   Time to onset of first 2Days Heartburn free, Days;   1Day Heartburn free days, %;   Time in Daytime of first Heartburn free, Days;   Time in Nighttime of first Heartburn free, Days;   Weekly Heartburn Improvement Rate, %;   Average Daytime and Nighttime Heartburn Score Change at W4;   Average Daytime and Nighttime Heartburn Score Change at W8
12 Unknown  A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study
Condition: Chest Pain
Intervention: Drug: Rabeprazole 20mg twice daily
Outcome Measures: Symptoms assessment, quality of life.;   Compliance;   Adverse effects
13 Unknown  Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Procedure: Transoral Incisionless Fundoplication;   Drug: Proton Pump Inhibitors; active control
Outcome Measures: GERD symptoms;   PPI usage;   Lower esophageal acid exposure;   Healed reflux esophagitis;   Rate of adverse events
14 Recruiting The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD
Condition: Gastroesophageal Reflux Disease
Intervention: Drug: Proton pump inhibitor (rabeprazole)
Outcome Measure: Symptom responders after PPI trials
15 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
Outcome Measure: Comparison of the antiplatelet drug response apparently shown in TEG & Platelet mapping assay
16 Recruiting The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
Conditions: Non-erosive Reflux Disease;   Barrett's Esophagus
Interventions: Device: Ryodoraku;   Device: ANSWatch;   Device: UGI endoscopy;   Other: GerdQ;   Drug: PPI
Outcome Measures: gastroesophageal reflux disease questionnaire;   Upper gastrointestinal endoscopy
17 Recruiting Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
Outcome Measures: to compare the efficacy of 10-day concomitant regimen versus high dose dual therapy used as atni-Helicobacter pylori rescue therapy;   to compare the adverse effects and patient adherence of 10-day concomitant regimen versus high dose dual therapy used as atni-Helicobacter pylori rescue therapy
18 Unknown  Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
Condition: Gastroesophageal Reflux Disease
Intervention:
Outcome Measure: The incidence and severity of acid-related symptoms with GerdQ